APA (7th ed.) Citation

Brodowicz, T., Ciuleanu, T. E., Radosavljevic, D., Shacham-Shmueli, E., Vrbanec, D., Plate, S., . . . Zielinski, C. C. (2013). FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: A randomized phase II CECOG study. Annals of Oncology, 24(7), 1769. https://doi.org/10.1093/annonc/mdt116

Chicago Style (17th ed.) Citation

Brodowicz, T., et al. "FOLFOX4 Plus Cetuximab Administered Weekly or Every Second Week in the First-line Treatment of Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Randomized Phase II CECOG Study." Annals of Oncology 24, no. 7 (2013): 1769. https://doi.org/10.1093/annonc/mdt116.

MLA (9th ed.) Citation

Brodowicz, T., et al. "FOLFOX4 Plus Cetuximab Administered Weekly or Every Second Week in the First-line Treatment of Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Randomized Phase II CECOG Study." Annals of Oncology, vol. 24, no. 7, 2013, p. 1769, https://doi.org/10.1093/annonc/mdt116.